Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Divi’s Laboratories Limited ( (IN:DIVISLAB) ) just unveiled an announcement.
Divi’s Laboratories Limited announced the closure of its trading window from July 1, 2025, until 48 hours after the release of its unaudited financial results for the quarter ending June 30, 2025. This move is in compliance with the company’s Code of Conduct to regulate trading by insiders and is a routine procedure aimed at ensuring transparency and preventing insider trading.
More about Divi’s Laboratories Limited
Divi’s Laboratories Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company is a significant player in the global pharmaceutical market, providing essential components for various medications.
Average Trading Volume: 19,594
Current Market Cap: 1767.5B INR
Learn more about DIVISLAB stock on TipRanks’ Stock Analysis page.